Obermatt
See Similar Stocks →

InMode

NSQ:INMD · IL0011595993
Health Care Equipment & SuppliesSmall

360

86
EV / EBIT100
Price / Owner Earnings41
Owner Earnings Yield100
Dividend Yield1
Price/Sales37
EV / Gross Profit95
Price/Book67
Return on Capital91
Cash Return on Capital86
Return on Equity87
EBIT Margin94
Gross Profitability62
Cash Conversion6
Accruals97
Owner Earnings Margin96
Sales growth14
Profit Growth68
Long-Term EPS Growth16
Owner Earnings Growth25
Reinvestment73
Price momentum47
Debt load97
Refinancing64
Debt Payback100
Liquidity1
Analyst ratings8
Opinion Changes10
Price Target Upside8
Market mood39
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

InMode clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryIsrael
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2008
Employees478
Websiteinmodemd.com
ISINIL0011595993
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
LifestyleDermatologyBiomedical EngineeringWomen's HealthPain ManagementUrologyEar Nose & Throat (ENT)Surgery

Description

InMode Ltd. provides energy-based, minimally invasive surgical medical treatment solutions. Within the global aesthetics market, the company's products and solutions are primarily designed to address three energy-based treatment categories, comprise…

Analysis

Hidden champion

InMode Ltd. fits the profile of a hidden champion, yet the market has not awarded it the premium its quality earns.

On valuation, the picture is attractive. The owner-earnings multiple stands at 9.8×; owner earnings: the cash an owner could take out each year.

Growth is tepid; the safety picture is sturdy. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
57
2023202420252026

All-time high

87

Jan 2023

All-time low

57

Mar 2026

Average rank

71

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
37
21
22
5
Price/Earnings
45
81
91
35
Price/Book
67
65
45
12
Dividend Yield
1
1
1
1
Value (overall)
38
46
41
7

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare InMode with its peers
SHL Telemedicine
SWX:SHLTN
24
CountryIsrael
IndustryHealth Care Providers & Services
SizeX-Small
Full Stock Analysis →
Pharming
AEX:PHARM
77
CountryNetherlands
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Mediwound
NMQ:MDWD
25
CountryIsrael
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Embla Medical
CPH:EMBLA
61
CountryIceland
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Leonardo DRS
NSQ:DRS
50
CountryItaly
IndustryAerospace & Defense
SizeLarge
Full Stock Analysis →
Kamada
NSQ:KMDA
82
CountryIsrael
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →